Detection of Methylated Circulating DNA as Noninvasive Biomarkers for Breast Cancer Diagnosis.

Abstract:

:Internationally, breast cancer is the most common female cancer, and is induced by a combination of environmental, genetic, and epigenetic risk factors. Despite the advancement of imaging techniques, invasive sampling of breast epithelial cells is the only definitive diagnostic procedure for patients with breast cancer. To date, molecular biomarkers with high sensitivity and specificity for the screening and early detection of breast cancer are lacking. Recent evidence suggests that the detection of methylated circulating cell-free DNA in the peripheral blood of patients with cancer may be a promising quantitative and noninvasive method for cancer diagnosis. Methylation detection based on a multi-gene panel, rather than on the methylation status of a single gene, may be used to increase the sensitivity and specificity of breast cancer screening. In this review, the results of 14 relevant studies, investigating the efficacy of cell-free DNA methylation screening for breast cancer diagnosis, have been summarized. The genetic risk factors for breast cancer, the methods used for breast cancer detection, and the techniques and limitations related to the detection of cell-free DNA methylation status, have also been reviewed and discussed. From this review, we conclude that the analysis of peripheral blood or other samples to detect differentially methylated cell-free DNA is a promising technique for use in clinical settings, and may improve the sensitivity of screening for both, early detection and disease relapse, and thus improve the future prognosis of patients with breast cancer.

journal_name

J Breast Cancer

journal_title

Journal of breast cancer

authors

Cheuk IW,Shin VY,Kwong A

doi

10.4048/jbc.2017.20.1.12

subject

Has Abstract

pub_date

2017-03-01 00:00:00

pages

12-19

issue

1

eissn

1738-6756

issn

2092-9900

journal_volume

20

pub_type

杂志文章,评审
  • Change in Estradiol Levels among Premenopausal Patients with Breast Cancer Treated Using Leuprolide Acetate 11.25 Milligrams 3-Month Depot and Tamoxifen.

    abstract::The combination of luteinizing hormone-releasing hormone analogs (LHRHa) with tamoxifen is used as a standard postoperative adjuvant therapy in patients with hormone receptor-positive/premenopausal breast cancer. Long-acting LHRHa formulations offer advantages in terms of patient convenience. However, data on the effe...

    journal_title:Journal of breast cancer

    pub_type: 杂志文章

    doi:10.4048/jbc.2020.23.e57

    authors: Lee YJ,Wu ZY,Kim HJ,Lee JW,Chung IY,Kim J,Lee SB,Son BH,Kim SB,Jung JH,Gong G,Ahn SH,Ko B

    更新日期:2020-10-26 00:00:00

  • Evolution of Health-Related Quality of Life in Breast Cancer Patients during the First Year of Follow-Up.

    abstract:PURPOSE:The objective of this study was to describe the evolution of health-related quality of life (HRQOL) in a cohort of breast cancer patients over 1 year after surgery and to analyse the predictive ability of HRQOL measurement instruments. METHODS:Observational, multicenter and prospective study of a cohort of bre...

    journal_title:Journal of breast cancer

    pub_type: 杂志文章

    doi:10.4048/jbc.2013.16.1.104

    authors: Moro-Valdezate D,Peiró S,Buch-Villa E,Caballero-Gárate A,Morales-Monsalve MD,Martínez-Agulló A,Checa-Ayet F,Ortega-Serrano J

    更新日期:2013-03-01 00:00:00

  • Associations between BRCA Mutations in High-Risk Breast Cancer Patients and Familial Cancers Other than Breast or Ovary.

    abstract:PURPOSE:We investigated the relationship between BRCA mutations and the distribution of familial cancers other than breast or ovary in high-risk breast cancer patients. METHODS:PATIENTS WITH BREAST CANCER WHO HAD AT LEAST ONE OF THE FOLLOWING RISK FACTORS WERE ENROLLED: reported family history of breast or ovarian can...

    journal_title:Journal of breast cancer

    pub_type: 杂志文章

    doi:10.4048/jbc.2012.15.3.283

    authors: Noh JM,Choi DH,Baek H,Nam SJ,Lee JE,Kim JW,Ki CS,Park W,Huh SJ

    更新日期:2012-09-01 00:00:00

  • Breast Cancer Subtype as a Predictor of Lymph Node Metastasis according to the SEER Registry.

    abstract:PURPOSE:Breast cancer subtype correlates with response to systemic therapy and overall survival (OS), but its impact on lymphatic spread is incompletely understood. In this study, we used the Surveillance, Epidemiology, and End Results registry to assess whether the subtype can predict the presence of nodal metastasis ...

    journal_title:Journal of breast cancer

    pub_type: 杂志文章

    doi:10.4048/jbc.2015.18.2.143

    authors: Mattes MD,Bhatia JK,Metzger D,Ashamalla H,Katsoulakis E

    更新日期:2015-06-01 00:00:00

  • The impact of local and regional recurrence on distant metastasis and survival in patients treated with breast conservation therapy.

    abstract:PURPOSE:We evaluated the effect of local recurrence (LR) and regional recurrence (RR) on distant metastasis and survival in patients treated with breast conservation therapy (BCT). METHODS:We analyzed 907 patients who were treated for invasive breast cancer between 1993 and 2006. With 53 months of follow-up, 28 patien...

    journal_title:Journal of breast cancer

    pub_type: 杂志文章

    doi:10.4048/jbc.2011.14.3.191

    authors: Lee JS,Kim SI,Park HS,Lee JS,Park S,Park BW

    更新日期:2011-09-01 00:00:00

  • Ribociclib-Related Stevens-Johnson Syndrome: Oncologic Awareness, Case Report, and Literature Review.

    abstract::Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis belong to a severe dermatopathic spectrum that includes frequently fatal mucocutaneous manifestations consisting of whole epidermal necrosis and sloughing with bullous transformation, blistering, and further skin detachment. Notably, cancer patients are at ...

    journal_title:Journal of breast cancer

    pub_type:

    doi:10.4048/jbc.2019.22.e44

    authors: López-Gómez V,Yarza R,Muñoz-González H,Revilla E,Enrech S,González-Valle O,Tolosa P,Ciruelos E

    更新日期:2019-09-18 00:00:00

  • A Case of Breast Cancer Brain Metastasis with a 16-Year Time Interval without Evidence of Cancer Recurrence.

    abstract::The median time of brain metastasis from the diagnosis of breast cancer is approximately 3 years. In this case report, a 69-year-old woman demonstrated cerebellar ataxia. Brain magnetic resonance imaging revealed enhanced lesions in bilateral cerebellar hemispheres. She had undergone surgery, radiation, and chemothera...

    journal_title:Journal of breast cancer

    pub_type:

    doi:10.4048/jbc.2017.20.2.212

    authors: Yamada SM,Tomita Y,Shibui S,Kurokawa T,Baba Y

    更新日期:2017-06-01 00:00:00

  • Efficiency of Cytokine-Induced Killer Cells in Combination with Chemotherapy for Triple-Negative Breast Cancer.

    abstract:Purpose:The treatment of triple-negative breast cancer (TNBC) remains challenging, due to the absence of estrogen, progesterone, and human epidermal growth factor receptors. This study was designed to evaluate the efficiency and safety of cytokine-induced killer (CIK) cell immunotherapy, following regular chemotherapy,...

    journal_title:Journal of breast cancer

    pub_type: 杂志文章

    doi:10.4048/jbc.2018.21.2.150

    authors: Li M,Wang Y,Wei F,An X,Zhang N,Cao S,Ren B,Zhang X,Ren X

    更新日期:2018-06-01 00:00:00

  • Tamoxifen and the Risk of Parkinson's Disease in Female Patients with Breast Cancer in Asian People: A Nationwide Population-Based Study.

    abstract:Purpose:Whether tamoxifen affects the risk of neurodegenerative disease is controversial. This nationwide population-based study investigated the risk of Parkinson's disease (PD) associated with tamoxifen treatment in female patients with breast cancer using Taiwan's National Health Insurance Research Database. Method...

    journal_title:Journal of breast cancer

    pub_type: 杂志文章

    doi:10.4048/jbc.2017.20.4.356

    authors: Hong CT,Chan L,Hu CJ,Lin CM,Hsu CY,Lin MC

    更新日期:2017-12-01 00:00:00

  • Comparison of Clinicopathological Features and Treatment Results between Invasive Lobular Carcinoma and Ductal Carcinoma of the Breast.

    abstract:PURPOSE:The purpose of this study was to assess the incidence of invasive lobular carcinoma (ILC) and to compare the clinicopathological features and treatment results after breast conserving surgery (BCS) followed by radiotherapy between ILC and invasive ductal carcinoma (IDC). METHODS:A total of 1,071 patients who u...

    journal_title:Journal of breast cancer

    pub_type: 杂志文章

    doi:10.4048/jbc.2015.18.3.285

    authors: Park JS,Choi DH,Huh SJ,Park W,Kim YI,Nam SJ,Lee JE,Kil WH

    更新日期:2015-09-01 00:00:00

  • Notch1 in Tumor Microvascular Endothelial Cells and Tumoral miR-34a as Prognostic Markers in Locally Advanced Triple-Negative Breast Cancer.

    abstract:Purpose:Triple-negative breast cancer (TNBC) is associated with poor prognosis with limited treatment options. Angiogenesis is known to be involved in the progression of TNBC, and targeting this pathway results in modest clinical benefits. In this study, we analyzed the role of tumor microvascular endothelial Notch1 (E...

    journal_title:Journal of breast cancer

    pub_type: 杂志文章

    doi:10.4048/jbc.2019.22.e56

    authors: Kim D,Lee J,Kang J,Kim SH,Yoo TK,Oh S,Lee A

    更新日期:2019-12-12 00:00:00

  • Role of Estrogen Receptor-α in the Regulation of Claudin-6 Expression in Breast Cancer Cells.

    abstract:PURPOSE:In our previous studies we showed that upregulating claudin-6 (CLDN6) expression may contribute to preventing breast cancer, and that 17β-estradiol induces a concentration- and time-related effect on CLDN6 mRNA and protein expression in MCF-7 cells. However, the mechanisms of 17β-estradiol regulation of CLDN6 a...

    journal_title:Journal of breast cancer

    pub_type: 杂志文章

    doi:10.4048/jbc.2011.14.1.20

    authors: Yafang L,Qiong W,Yue R,Xiaoming X,Lina Y,Mingzi Z,Ting Z,Yulin L,Chengshi Q

    更新日期:2011-03-01 00:00:00

  • Enhanced radiosensitivity and chemosensitivity of breast cancer cells by 2-deoxy-d-glucose in combination therapy.

    abstract::Breast cancer is the most common malignancy, and it is also the major cause of cancer-related deaths of women worldwide. Breast cancer treatment involves surgery, chemotherapy, radiation therapy, or combination therapy, and novel strategies are needed to boost the oncologic outcome. The non-metabolizable glucose analo...

    journal_title:Journal of breast cancer

    pub_type: 杂志文章

    doi:10.4048/jbc.2012.15.2.141

    authors: Aghaee F,Pirayesh Islamian J,Baradaran B

    更新日期:2012-06-01 00:00:00

  • ESR1 Mutation Detection and Dynamics in Meningeal Carcinomatosis in Breast Cancer.

    abstract::ESR1 mutation is frequently encountered in hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer (MBC), especially after aromatase inhibitor (AI) therapy, as a mechanism of resistance to endocrine therapy. Circulating tumor DNA-based detection of ESR1 mutatio...

    journal_title:Journal of breast cancer

    pub_type:

    doi:10.4048/jbc.2020.23.e4

    authors: Carausu M,Melaabi S,Pierga JY,Bidard FC,Cabel L

    更新日期:2019-12-19 00:00:00

  • Differentiating lymphovascular invasion from retraction artifact on histological specimen of breast carcinoma and their implications on prognosis.

    abstract::On a pathological specimen of breast cancer cells, retraction artifact during histological processing mimics true lymphovascular invasion (LVI). The accurate determination of the presence or absence of LVI is a factor in determining risk of having a positive sentinel node, or having additional positive axillary nodes ...

    journal_title:Journal of breast cancer

    pub_type: 杂志文章

    doi:10.4048/jbc.2012.15.4.478

    authors: Zaorsky NG,Patil N,Freedman GM,Tuluc M

    更新日期:2012-12-01 00:00:00

  • Effect Modification of Hormonal Therapy by p53 Status in Invasive Breast Cancer.

    abstract:PURPOSE:We aimed to confirm the prognostic and predictive value of p53 expression, particularly in invasive breast cancer patients, according to immunohistochemical hormone receptor (HR) and human epidermal growth factor receptor 2 (HER2) status. METHODS:Immunohistochemical data for p53, estrogen receptor, progesteron...

    journal_title:Journal of breast cancer

    pub_type: 杂志文章

    doi:10.4048/jbc.2013.16.4.386

    authors: Ahn SH,Kim HJ,Han W,Cho J,Gong G,Jung KH,Kim SB,Son BH,Lee JW

    更新日期:2013-12-01 00:00:00

  • Ultrasonography-guided surgical clip placement for tumor localization in patients undergoing neoadjuvant chemotherapy for breast cancer.

    abstract:PURPOSE:We investigated the feasibility of using surgical clips as markers for tumor localization and their effect on the imaging evaluation of treatment responses after neoadjuvant chemotherapy (NAC). METHODS:A total of 16 breast cancers confirmed by needle biopsy in 15 patients were included in this study from Octob...

    journal_title:Journal of breast cancer

    pub_type: 杂志文章

    doi:10.4048/jbc.2015.18.1.44

    authors: Youn I,Choi SH,Kook SH,Choi YJ,Park CH,Park YL,Kim DH

    更新日期:2015-03-01 00:00:00

  • Validation of risk assessment models for predicting the incidence of breast cancer in korean women.

    abstract:PURPOSE:The Gail model is one of the most widely used tools to assess the risk of breast cancer. However, it is known to overestimate breast cancer risk for Asian women. Here, we validate the Gail model and the Korean model using Korean data, and subsequently update and revalidate the Korean model using recent data. M...

    journal_title:Journal of breast cancer

    pub_type: 杂志文章

    doi:10.4048/jbc.2014.17.3.226

    authors: Min JW,Chang MC,Lee HK,Hur MH,Noh DY,Yoon JH,Jung Y,Yang JH,Korean Breast Cancer Society.

    更新日期:2014-09-01 00:00:00

  • Oncoplastic surgical techniques for personalized breast conserving surgery in breast cancer patient with small to moderate sized breast.

    abstract::Oncoplastic surgery has revolutionized the field of breast conserving surgery (BCS). The final aims of this technique are to obtain an adequate resection margin that will reduce the rate of local recurrence while simultaneously improving cosmetic outcomes. To obtain successful results after oncoplastic surgery, it is ...

    journal_title:Journal of breast cancer

    pub_type: 杂志文章

    doi:10.4048/jbc.2011.14.4.253

    authors: Yang JD,Lee JW,Kim WW,Jung JH,Park HY

    更新日期:2011-12-01 00:00:00

  • Multiple Symmetric Lipomatosis (Madelung's Disease) Presenting as Bilateral Huge Gynecomastia.

    abstract::Multiple symmetric lipomatosis (MSL), or Madelung's disease, is a rare disease of unknown etiology. It is characterized by the presence of loose adipose tissue deposits localized in the cervical region and upper body. MSL presenting as bilateral huge gynecomastia is an extremely rare phenomenon. The present report des...

    journal_title:Journal of breast cancer

    pub_type:

    doi:10.4048/jbc.2014.17.4.397

    authors: Jang JH,Lee A,Han SA,Ryu JK,Song JY

    更新日期:2014-12-01 00:00:00

  • Association between BRCA Mutation Status, Pathological Findings, and Magnetic Resonance Imaging Features in Patients with Breast Cancer at Risk for the Mutation.

    abstract:PURPOSE:We investigated the relationship between BRCA mutations, pathological findings, and magnetic resonance imaging (MRI) features in patients with breast cancer at risk for the mutation. METHODS:Genetic testing for BRCA mutations was performed in 275 breast cancer patients with at least one risk factor for the mut...

    journal_title:Journal of breast cancer

    pub_type: 杂志文章

    doi:10.4048/jbc.2013.16.3.308

    authors: Noh JM,Han BK,Choi DH,Rhee SJ,Cho EY,Huh SJ,Park W,Park H,Nam SJ,Lee JE,Kil WH

    更新日期:2013-09-01 00:00:00

  • Loss of Tumor Suppressor ARID1A Protein Expression Correlates with Poor Prognosis in Patients with Primary Breast Cancer.

    abstract:PURPOSE:Somatic mutations of the chromatin remodeling AT-rich interactive domain 1A (SWI-like) gene (ARID1A) have been identified in many human cancers, including breast cancer. The purpose of this study was to evaluate the nuclear expression of ARID1A in breast cancers by immunohistochemistry (IHC) and to correlate th...

    journal_title:Journal of breast cancer

    pub_type: 杂志文章

    doi:10.4048/jbc.2015.18.4.339

    authors: Cho HD,Lee JE,Jung HY,Oh MH,Lee JH,Jang SH,Kim KJ,Han SW,Kim SY,Kim HJ,Bae SB,Lee HJ

    更新日期:2015-12-01 00:00:00

  • Apocrine Encapsulated Papillary Carcinoma of the Breast: The First Reported Case with an Infiltrative Component.

    abstract::Apocrine encapsulated papillary carcinoma (EPC) of the breast is a rare neoplasm, and only 10 cases have been reported in the literature to date. Although EPC by definition lacks a peripheral myoepithelial layer, all previously published apocrine EPC cases were clinically indolent and lacked a conventional invasive co...

    journal_title:Journal of breast cancer

    pub_type:

    doi:10.4048/jbc.2018.21.2.227

    authors: Kővári B,Ormándi K,Simonka Z,Vörös A,Cserni G

    更新日期:2018-06-01 00:00:00

  • Insights into Hypoxia: Non-invasive Assessment through Imaging Modalities and Its Application in Breast Cancer.

    abstract::Oxygen is crucial to maintain the homeostasis in aerobic cells. Hypoxia is a condition in which cells are deprived of the oxygen supply necessary for their optimum performance. Whereas oxygen deprivation may occur in normal physiological processes, hypoxia is frequently associated with pathological conditions. It has ...

    journal_title:Journal of breast cancer

    pub_type: 杂志文章,评审

    doi:10.4048/jbc.2019.22.e26

    authors: Daimiel I

    更新日期:2019-05-13 00:00:00

  • Hyperglycemia during Adjuvant Chemotherapy as a Prognostic Factor in Breast Cancer Patients without Diabetes.

    abstract:Purpose:Breast cancer treatments, including chemotherapy, administered in combination with glucocorticoids can induce hyperglycemia. This study aimed to investigate the effect of hyperglycemia during adjuvant chemotherapy on the prognosis of breast cancer patients without a known history of diabetes. Methods:In this s...

    journal_title:Journal of breast cancer

    pub_type: 杂志文章

    doi:10.4048/jbc.2020.23.e44

    authors: Ahn HR,Kang SY,Youn HJ,Jung SH

    更新日期:2020-08-05 00:00:00

  • CD49f Can Act as a Biomarker for Local or Distant Recurrence in Breast Cancer.

    abstract:PURPOSE:Metastasis and local recurrence are the primary causes of treatment failure and patient death in breast cancer. The aim of this study was to validate a metastasis- and local recurrenceassociated biomarker for prognostic evaluation and planning treatment strategies. METHODS:Formalin-fixed, paraffin-embedded tis...

    journal_title:Journal of breast cancer

    pub_type: 杂志文章

    doi:10.4048/jbc.2017.20.2.142

    authors: Ye F,Zhong X,Qiu Y,Yang L,Wei B,Zhang Z,Bu H

    更新日期:2017-06-01 00:00:00

  • Copy Number Profiling of MammaPrint™ Genes Reveals Association with the Prognosis of Breast Cancer Patients.

    abstract:PURPOSE:The MammaPrint™ gene signature, currently used in clinical practice, provides prognostic information regarding the recurrence and potential metastasis in breast cancer patients. However, the prognostic information of the 70 genes included can only be estimated at the RNA expression level. In this study, we inve...

    journal_title:Journal of breast cancer

    pub_type: 杂志文章

    doi:10.4048/jbc.2017.20.3.246

    authors: Fatima A,Tariq F,Malik MFA,Qasim M,Haq F

    更新日期:2017-09-01 00:00:00

  • Analysis of predictive factors for lung injury after forward-planned intensity-modulated radiotherapy in whole breast irradiation.

    abstract:PURPOSE:This study was performed to assess frequency, timings of occurrence, and predictors of radiologic lung damage (RLD) after forward-planned intensity-modulated radiotherapy (FIMRT) for whole breast irradiation. METHODS:We retrospectively reviewed medical records of 157 breast cancer patients and each of their se...

    journal_title:Journal of breast cancer

    pub_type: 杂志文章

    doi:10.4048/jbc.2014.17.1.69

    authors: Kim H,Bae H,Lee MY,Cheong KH,Kim KJ,Han T,Kang SK,Park S,Hwang T,Yoon JW,Kim LS

    更新日期:2014-03-01 00:00:00

  • A case report of breast cancer with extensive pulmonary lymphovascular tumor emboli.

    abstract::We describe a patient with breast cancer who relapsed with an extensive pulmonary lymphovascular tumor embolism. A 38-year-old female, who previously received neoadjuvant chemotherapy and curative resection of breast cancer, underwent adjuvant chemotherapy and was referred to the emergency room because of sudden-onset...

    journal_title:Journal of breast cancer

    pub_type:

    doi:10.4048/jbc.2012.15.1.128

    authors: Yang Y,Choi Y,Beom SH,Kim JW,Joen YK,Kim NJ,Kim JH,Im SA,Lee KH

    更新日期:2012-03-01 00:00:00

  • Factors Associated with Re-excision after Breast-Conserving Surgery for Early-Stage Breast Cancer.

    abstract:PURPOSE:Re-excisions after breast-conserving surgery (BCS) for breast cancer cause delays in the adjuvant treatment, increased morbidity, and leads to poor aesthetic results. Thus, efforts to reduce the re-excision rate are essential. This study aimed to conclusively determine the re-excision rate and the factors assoc...

    journal_title:Journal of breast cancer

    pub_type: 杂志文章

    doi:10.4048/jbc.2012.15.4.412

    authors: Jung W,Kang E,Kim SM,Kim D,Hwang Y,Sun Y,Yom CK,Kim SW

    更新日期:2012-12-01 00:00:00